EW Stock to Benefit From Favorable RHEIA Trial Data on TAVI
Edwards' first all-female TAVI Trial demonstrates favorable outcomes for women receiving Edwards valves.
| Ticker |
Sentiment |
Impact |
|
AXGN
|
Neutral
|
10 %
|
|
EW
|
Neutral
|
14 %
|
|
EXAS
|
Neutral
|
19 %
|
|
BDX
|
Somewhat Bullish
|
5 %
|
